DECEMBER 2024LIFE SCIENCES REVIEW5CXO INSIGHTS18Meiji Holdings (TYO: 2269)20Nahls CorporationMotoji Kawasaki, President and CEO23PharmaBio CorporationDr. Hitoshi Kusano,CEO26Quantum Flowers & FoodsNorio Kikuchi, CEO, CTO and FounderFEATURED COMPANIESBIOTECHCOMPANIES IN JAPAN 2024TOP 1029Immunotherapy: Unleashing the Power of the Immune System in Cancer TreatmentClement Lim, Director, Head of Early Cancer Detection, Scientific & Medical Affairs, Mirxes27Shaping the Next Chapter of ManufacturingChow Woai Sheng, Vice President / General Manager, Global Instrument Manufacturing, Agilent Technologies21Key Considerations for the Evolving Cell Therapy LandscapePrue Cowin B.BiomedSci (Hons) PhD,Partner, FB Rice andDr Sarah Tregenza BSc(Hons) PhD,APAC Oncology Medical Affairs Director,Pierre Fabre Group19Clinical Trials Landscape in APAC and Its Unique Characteristics and OpportunitiesMarcia Matos, Clinical Operations HUB Director for APAC,SERVIERProtein Immuno-Engineering LaboratoriesShinji Fujino, Co-Founder and CEOYutaka Kuroda, PhD, Co-Founder and CSO24
< Page 4 | Page 6 >